Tools for Academic Research
Cognitive & Neurological Research
Key Facts
About Cognision
Cognision operates at the intersection of neuroscience and digital health, providing a unified platform called Cognision360™ for electronic-sourced digital biomarkers in central nervous system (CNS) clinical trials and research. The company leverages quantitative EEG (qEEG), Event-Related Potentials (ERP), polysomnography, eye-tracking, and wearable sensor data to deliver objective measures of cognitive and cortical function. Its technology is positioned to address the need for sensitive, reliable, and scalable tools in drug development for neurological disorders and cognitive research. As a private company, it appears to be in an early-revenue or pre-revenue stage, serving biopharma clients and research institutions.
View full company profile